Gear Up for Intuitive Surgical (ISRG) Q1 Earnings: Wall Street Estimates for Key Metrics

16.04.25 15:15 Uhr

Werte in diesem Artikel
Aktien

422,95 EUR 3,20 EUR 0,76%

Indizes

PKT PKT

18.258,1 PKT 0,5 PKT 0,00%

16.286,5 PKT -20,7 PKT -0,13%

5.282,7 PKT 7,0 PKT 0,13%

In its upcoming report, Intuitive Surgical, Inc. (ISRG) is predicted by Wall Street analysts to post quarterly earnings of $1.71 per share, reflecting an increase of 14% compared to the same period last year. Revenues are forecasted to be $2.18 billion, representing a year-over-year increase of 15.4%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.2% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.In light of this perspective, let's dive into the average estimates of certain Intuitive Surgical metrics that are commonly tracked and forecasted by Wall Street analysts.Analysts expect 'Revenue- Product (Instruments and accessories and Systems)' to come in at $1.55 billion. The estimate indicates a change of -1.7% from the prior-year quarter.Analysts' assessment points toward 'Revenue- Services' reaching $356.83 million. The estimate indicates a change of +13.8% from the prior-year quarter.Based on the collective assessment of analysts, 'Revenue- Systems' should arrive at $481.95 million. The estimate points to a change of +15.2% from the year-ago quarter.The combined assessment of analysts suggests that 'Revenue- Instruments and accessories' will likely reach $1.33 billion. The estimate indicates a year-over-year change of +14.6%.The consensus among analysts is that 'Total System Units Placed - Total Company' will reach 349. The estimate is in contrast to the year-ago figure of 313.The consensus estimate for 'Da Vinci Surgical System Installed Base' stands at 10,194. The estimate is in contrast to the year-ago figure of 8,887.The collective assessment of analysts points to an estimated 'Total System Units Placed - Outside of the United States' of 175. The estimate is in contrast to the year-ago figure of 165.The average prediction of analysts places 'Total System Units Placed - United States' at 181. The estimate compares to the year-ago value of 148.Analysts forecast 'Gross profit- Service' to reach $236.25 million. Compared to the present estimate, the company reported $222.70 million in the same quarter last year.Analysts predict that the 'Cost of revenue- Service' will reach $113.02 million. Compared to the current estimate, the company reported $90.80 million in the same quarter of the previous year.View all Key Company Metrics for Intuitive Surgical here>>>Intuitive Surgical shares have witnessed a change of +0.9% in the past month, in contrast to the Zacks S&P 500 composite's -4.2% move. With a Zacks Rank #3 (Hold), ISRG is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Intuitive Surgical und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Intuitive Surgical

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Intuitive Surgical Inc

Wer­bung

Analysen zu Intuitive Surgical Inc

DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
26.01.2018Intuitive Surgical HoldCanaccord Adams
18.07.2017Intuitive Surgical Sector PerformRBC Capital Markets
30.06.2017Intuitive Surgical NeutralCantor Fitzgerald
30.05.2017Intuitive Surgical HoldCanaccord Adams
17.04.2017Intuitive Surgical Sector PerformRBC Capital Markets
DatumRatingAnalyst
23.01.2015Intuitive Surgical SellCRT Capital
22.10.2014Intuitive Surgical SellCRT Capital
09.01.2009Intuitive Surgical DowngradeBrean Murray, Carret & Co., LLC
26.08.2005Update Intuitive Surgical Inc. : UnderperformJefferies & Co

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen